Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| USANA HEALTH SCIENCES INCUSNA · Entity 6114 | 10% owner | September 03, 2025 | September 05, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
USANA HEALTH SCIENCES INC
Report date September 03, 2025 · Filed September 05, 2025
Jointly reported with Gull Global Ltd
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectShares owned of record by Gull Global Limited | 7,408,345 |
Reported balance
After 2025-09-03 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-09-03 · Gift · Disposed 145,000 · Balance 7,408,345 F1: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. |
Filing footnotes · ownership attribution and instrument terms
F1: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2025 Filed Sep 5, 2025 14:13 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GiftCommon Stock | 145,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-087682 · tm2525370-1_4seq1.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · 10% owner Gull Global Ltd · CIK 0001636301 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 7,408,345 F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. Read SEC document |
| May 02, 2025 Filed May 6, 2025 19:43 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GiftCommon Stock | 188,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-045016 · tm2514140-2_4seq1.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · 10% owner Gull Global Ltd · CIK 0001636301 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 7,553,345 F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. Read SEC document |
| November 13, 2024 Filed Nov 18, 2024 14:45 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GiftCommon Stock | 123,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-119995 · tm2428694-1_4seq1.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · 10% owner Gull Global Ltd · CIK 0001636301 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 7,741,345 F1 · ownership.direct: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. Read SEC document |
| June 14, 2024 Filed Jun 15, 2024 00:32 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 13,496 | $45.03 | $607,724.88 |
DisclosureSEC source: 0001104659-24-071894 · tm2417383-1_4seq1.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · 10% owner Gull Global Ltd · CIK 0001636301 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 7,864,345 F2 · price: Represents the weighted average price rounded to the nearest hundredths. Actual prices in multiple transactions ranged from $45.00 to $45.125, inclusive. The reporting persons undertake to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the range set forth. F3 · ownership.direct: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. F3 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. Read SEC document |
| June 12, 2024 Filed Jun 15, 2024 00:32 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 2,202 | $47.79 | $105,233.58 |
DisclosureSEC source: 0001104659-24-071894 · tm2417383-1_4seq1.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · 10% owner Gull Global Ltd · CIK 0001636301 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 7,877,841 F1 · price: Represents the weighted average price rounded to the nearest hundredths. Actual prices in multiple transactions ranged from $47.50 to $48.03, inclusive. The reporting persons undertake to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the range set forth. F3 · ownership.direct: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. F3 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. Read SEC document |
| June 07, 2024 Filed Jun 12, 2024 01:56 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 3,700 | $48.61 | $179,857.00 |
DisclosureSEC source: 0001104659-24-070582 · tm2417043-1_4seq1.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · 10% owner Gull Global Ltd · CIK 0001636301 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 7,880,043 F1 · ownership.direct: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 00:41 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GiftCommon Stock | 102,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-126099 · tm2332915-1_4seq1.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · 10% owner Gull Global Ltd · CIK 0001636301 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 7,883,743 F1 · ownership.direct: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited and 50% by Myogen Limited, each of which is a company formed under the Commonwealth of the Bahamas and is wholly indirectly owned and controlled by Dr. Wentz. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:02 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 500,000 | $95.00 | $47,500,000.00 |
DisclosureSEC source: 0001104659-21-034989 · tm219476d1_form4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · 10% owner Gull Global Ltd · CIK 0001636301 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 7,985,743 F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited, a company formed under the Commonwealth of the Bahamas ("Viron"), and 50% by Myogen Limited, a company formed under the Commonwealth of the Bahamas ("Myogen"), and each of which is wholly indirectly owned and controlled by Dr. Wentz. Read SEC document |
| August 21, 2020 Filed Aug 24, 2020 18:12 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 600,000 | $80.00 | $48,000,000.00 |
DisclosureSEC source: 0001104659-20-097898 · tm2029277-1_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · 10% owner Gull Global Ltd · CIK 0001636301 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 8,485,743 F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is directly owned 50% by Viron Company Limited, a company formed under the Commonwealth of the Bahamas ("Viron"), and 50% by Myogen Limited, a company formed under the Commonwealth of the Bahamas ("Myogen"), and each of which is wholly indirectly owned and controlled by Dr. Wentz. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:57 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 641,270 | $80.75 | $51,782,552.50 |
DisclosureSEC source: 0001104659-20-058215 · tm2018973d1_form4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director Gull Global Ltd · CIK 0001636301 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,085,743 F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is a 10% Owner of the Issuer. Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 21:02 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 8,730 | $86.43 | $754,533.90 |
DisclosureSEC source: 0001104659-20-054545 · tm2018291-1_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director Gull Global Ltd · CIK 0001636301 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,727,013 F1 · price: Represents the weighted average price rounded to the nearest hundredths. Actual prices in multiple transactions ranged from $86.13 to $86.44, inclusive. The reporting persons undertake to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the range set forth. F2 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Gull Global Limited is a 10% Owner of the Issuer. Read SEC document |
| December 27, 2019 Filed Feb 11, 2020 17:16 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GiftCommon Stock | 129,871 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-016112 · tm207422d2_5.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director Gull Global Ltd · CIK 0001636301 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,735,743 F1 · ownership.direct: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron Wentz. Gull Global Limited is a 10% Owner of the Issuer. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron Wentz. Gull Global Limited is a 10% Owner of the Issuer. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 22:26 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 800 | $116.90 | $93,520.00 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 8 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,865,614 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F11 · price: Weighted average price. Price range in multiple transactions was $116.82 to $117.00, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 22:26 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 4,555 | $116.32 | $529,837.60 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 7 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,866,414 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $115.82 to $116.76, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 22:26 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 2,600 | $115.32 | $299,832.00 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 6 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,870,969 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $114.82 to $115.81, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 22:26 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,400 | $114.19 | $159,866.00 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 5 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,873,569 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $113.70 to $114.68, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:26 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 719 | $116.97 | $84,101.43 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 4 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,874,969 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $116.94 to $117.10, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:26 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 8,354 | $116.20 | $970,734.80 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,875,688 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $115.94 to $116.80, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:26 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 2,910 | $115.57 | $336,308.70 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,884,042 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $114.94 to $115.93, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:26 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 8,662 | $114.34 | $990,413.08 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,886,952 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $113.94 to $114.93, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F12 · balance_after: The total number of outstanding shares reflects 300 shares fewer than the total number of shares last reported as beneficially owned on a Form 4 filed on January 4, 2019, which 300 shares were sold on January 4, 2019, at an average weighted price of $115.00, with actual prices ranging from $114.71 to $115.67 (and were in addition to the sales reported on the Form 4 filed on January 4, 2019). F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 00:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 160 | $116.11 | $18,577.60 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 11 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,895,914 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F13 · price: Weighted average price. Price range in multiple transactions was $116.10 to $116.13, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 00:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 4,474 | $115.00 | $514,510.00 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 10 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,896,074 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F12 · price: Weighted average price. Price range in multiple transactions was $114.71 to $115.67, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 00:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 3,223 | $114.23 | $368,163.29 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 9 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,900,548 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F11 · price: Weighted average price. Price range in multiple transactions was $113.71 to $114.69, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 00:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,700 | $113.17 | $192,389.00 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 8 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,903,771 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $112.67 to $113.66, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 00:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 100 | $115.97 | $11,597.00 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 7 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,905,471 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 00:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 700 | $115.25 | $80,675.00 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 6 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,905,571 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $114.67 to $115.56, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 00:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 2,316 | $113.86 | $263,699.76 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 5 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,906,271 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $113.57 to $114.46, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 00:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 7,096 | $113.07 | $802,344.72 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 4 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,908,587 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $112.53 to $113.51, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 02, 2019 Filed Jan 5, 2019 00:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 200 | $117.68 | $23,536.00 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,915,683 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $117.65 to $117.70, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 02, 2019 Filed Jan 5, 2019 00:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 2,600 | $117.00 | $304,200.00 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,915,883 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $116.64 to $117.61, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 02, 2019 Filed Jan 5, 2019 00:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 7,131 | $116.25 | $828,978.75 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,918,483 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $115.64 to $116.60, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 11:01 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 200 | $121.16 | $24,232.00 |
DisclosureSEC source: 0001144204-18-063192 · tv508528_4.xml · nonDerivative · entry 6 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,925,614 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 11:01 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 5,648 | $120.57 | $680,979.36 |
DisclosureSEC source: 0001144204-18-063192 · tv508528_4.xml · nonDerivative · entry 5 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,925,814 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $120.10 to $121.09, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 11:01 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 8,778 | $119.70 | $1,050,726.60 |
DisclosureSEC source: 0001144204-18-063192 · tv508528_4.xml · nonDerivative · entry 4 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,931,462 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $119.10 to $120.09, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 11:01 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 743 | $122.72 | $91,180.96 |
DisclosureSEC source: 0001144204-18-063192 · tv508528_4.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,940,240 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $122.38 to $123.00, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 11:01 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,929 | $121.50 | $234,373.50 |
DisclosureSEC source: 0001144204-18-063192 · tv508528_4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,940,983 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $121.19 to $122.16, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 11:01 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 12,702 | $120.87 | $1,535,290.74 |
DisclosureSEC source: 0001144204-18-063192 · tv508528_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,942,912 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $120.18 to $121.17, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| November 02, 2018 Filed Nov 3, 2018 00:12 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 945 | $113.76 | $107,503.20 |
DisclosureSEC source: 0001144204-18-057141 · tv506243_4.xml · nonDerivative · entry 7 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,955,614 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $113.70 to $113.84, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| November 02, 2018 Filed Nov 3, 2018 00:12 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 3,591 | $113.11 | $406,178.01 |
DisclosureSEC source: 0001144204-18-057141 · tv506243_4.xml · nonDerivative · entry 6 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,956,559 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $112.69 to $113.65, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| November 01, 2018 Filed Nov 3, 2018 00:12 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 6,952 | $117.01 | $813,453.52 |
DisclosureSEC source: 0001144204-18-057141 · tv506243_4.xml · nonDerivative · entry 5 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,960,150 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $116.82 to $117.16, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| November 01, 2018 Filed Nov 3, 2018 00:12 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,260 | $115.74 | $145,832.40 |
DisclosureSEC source: 0001144204-18-057141 · tv506243_4.xml · nonDerivative · entry 4 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,967,102 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $115.60 to $115.76, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| November 01, 2018 Filed Nov 3, 2018 00:12 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,890 | $115.07 | $217,482.30 |
DisclosureSEC source: 0001144204-18-057141 · tv506243_4.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,968,362 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $114.55 to $115.49, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| November 01, 2018 Filed Nov 3, 2018 00:12 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,643 | $114.16 | $187,564.88 |
DisclosureSEC source: 0001144204-18-057141 · tv506243_4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,970,252 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $113.55 to $114.51, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| November 01, 2018 Filed Nov 3, 2018 00:12 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 13,719 | $112.81 | $1,547,640.39 |
DisclosureSEC source: 0001144204-18-057141 · tv506243_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,971,895 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $112.50 to $113.46, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 00:37 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 7,605 | $120.55 | $916,782.75 |
DisclosureSEC source: 0001144204-18-051887 · tv503956_4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,985,614 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $120.44 to $120.68, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 00:37 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 22,395 | $119.66 | $2,679,785.70 |
DisclosureSEC source: 0001144204-18-051887 · tv503956_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,993,219 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $119.44 to $120.40, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 00:05 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,226 | $125.41 | $153,752.66 |
DisclosureSEC source: 0001144204-18-048363 · tv502475_4.xml · nonDerivative · entry 9 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,015,614 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F12 · price: Weighted average price. Price range in multiple transactions was $124.85 to $125.80, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 00:05 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 2,627 | $124.42 | $326,851.34 |
DisclosureSEC source: 0001144204-18-048363 · tv502475_4.xml · nonDerivative · entry 8 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,016,840 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F11 · price: Weighted average price. Price range in multiple transactions was $123.85 to $124.80, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 00:05 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 1,835 | $123.28 | $226,218.80 |
DisclosureSEC source: 0001144204-18-048363 · tv502475_4.xml · nonDerivative · entry 7 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,019,467 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $122.85 to $123.75, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| September 05, 2018 Filed Sep 7, 2018 00:05 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 5,483 | $125.95 | $690,583.85 |
DisclosureSEC source: 0001144204-18-048363 · tv502475_4.xml · nonDerivative · entry 6 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 10,021,302 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $125.85 to $126.20, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.